Vijayawada: The Andhra Pradesh government aims to administer the Covid-19 vaccine, called CorBevax, to 14.90 lakh children aged between 12 and 14 years by taking up a special campaign in schools from March 21. Though state health authorities started administering the Covid jab to the targeted children at Covid Vaccination Centres from March 16 in…Continue Reading
Biological E Ltd, a Hyderabad-based pharmaceutical business, announced on Monday that its coronavirus vaccine, Corbevax, has acquired emergency use approval in India for children aged 12 to 18. Corbevax is India’s third homegrown vaccine. The Drug Controller General of India (DCGI), Dr. V. G. Somani, granted the approval for Corbevax. So far, only children aged…Continue Reading
The Drugs Controller General Of India (DCGI) has already approved Corbevax for restricted use in emergency situation in adults on December 28…Continue Reading
India’s first indigenously-developed receptor binding domain (RBD) protein sub-unit Covid-19 vaccine, Corbevax, developed by Biological E Ltd, has received the Drug Controller General of India’s approval for Emergency Use Authorization (EUA).The Department of Biotechnology and its public sector undertaking, the Biotechnology Industry Research Assistance Council (BIRAC), had supported Biological E’s Covid-19 vaccine candidate from pre-clinical…Continue Reading